Security record · archived quarter
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
19Tracked holders
0Δ holders
46.24MShares held
$21.49BReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -0.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.02M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 26.81M | +0.4% | $12.47B | 1.9% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 5.94M | -6.2% | $2.75B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 5.94M | -6.2% | $2.75B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 3.41M | -0.6% | $1.59B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 1.77M | -20.1% | $822.27M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.77M | -20.1% | $822.27M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 1.63M | +4.2% | $758.77M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 346.36K | +3.3% | $161.08M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 244.00K | +92.1% | $113.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 160.53K | -51.6% | $74.66M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 159.29K | +11.6% | $74.08M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 138.41K | -18.6% | $64.37M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 138.41K | -18.6% | $64.37M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 29 | Tweedy, Browne ✦ | 53.60K | -1.4% | $24.93M | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 30 | ARK Investment Management ✦ | 51.10K | -32.3% | $23.76M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 50.23K | -52.0% | $23.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 50.23K | -52.0% | $23.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | Gotham Asset Management ✦ | 27.13K | +9.8% | $12.62M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | Fisher Asset Management ✦ | 27.02K | -3.9% | $12.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Bridgewater Associates ✦ | 3.45K | -89.6% | $1.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,678 holders, 225.07M shares, $98.10B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API